Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
UFPT Transcript
UFP Technologies, Inc. (UFPT) Q1 2026 Earnings Call Transcript
Positive5-5
The company's financial performance is strong, with a 10% revenue increase, improved gross margin, and significant EPS growth. Despite potential risks, the strategic initiatives and robust financial metrics suggest a positive outlook. The market cap indicates moderate reaction sensitivity, leading to a 'Positive' prediction for the stock price over the next two weeks.
UFP Technologies, Inc. (UFPT) Q4 2025 Earnings Call Transcript
Positive2-25
The earnings call shows strong sales growth and EPS increase, despite some operational inefficiencies. The company has a strategic plan to overcome these inefficiencies and is making progress in its operations. The Q&A reveals management's confidence in handling current challenges and future growth, especially with new programs and partnerships. While there are some uncertainties, such as the AJR backlog and cybersecurity incident, they are being managed effectively. The market cap suggests a moderate reaction, leading to a positive stock price movement prediction.
UFP Technologies, Inc. (UFPT) Q3 2025 Earnings Call Transcript
Positive11-4
The earnings call reflects a positive sentiment with key highlights: a 5.1% increase in robotic surgery revenue, strong demand in interventional orthopedics, and successful acquisitions. Despite AJR's labor issues, the company maintains a stable operating margin and continues debt reduction. The Q&A section reveals optimism about future contracts and growth, particularly with Intuitive. Although AJR inefficiencies impact margins, improvements are anticipated. The market cap suggests moderate sensitivity to these developments, leading to a positive stock price prediction.
UFP Technologies, Inc. (UFPT) Q2 2025 Earnings Call Transcript
Positive8-5
The earnings call highlights strong revenue growth, especially in the medical business and with key customers like Stryker. Despite labor inefficiencies impacting margins, the company expects recovery by Q4. The Q&A session reveals optimism in robotic surgery opportunities and resolved inventory issues. The strategic expansion in the Dominican Republic and selective M&A activity further support positive sentiment. Given the market cap of $1.98 billion, these factors suggest a positive stock price movement of 2% to 8% over the next two weeks.
UFPT Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
